文献速递腹部MR

葡萄糖作为刺激剂在肝硬化及肝细胞癌BOLD功能磁共振成像中的应用:可行性研究

Glucose as a stimulation agent in the BOLD functional magnetic resonance imaging for liver cirrhosis and hepatocellular carcinoma: a feasibility study.
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

本研究纳入20例肝硬化肝细胞癌患者和10名健康志愿者,口服葡萄糖前后行BOLD fMRI测量正常肝实质、肝癌肝实质、肝癌中心及肝癌边缘的T2*值。结果显示正常肝实质、肝癌肝实质及肝癌中心T2*值前后差异有统计学意义(p<0.01),肝癌边缘无统计学差异(p=0.35);ΔT2*在健康志愿者与肝癌患者肝实质间及肝癌中心与边缘间差异有统计学意义(均p<0.01)。作者认为葡萄糖作为BOLD fMRI刺激剂可能有助于评估肝硬化患者肝功能,ΔT2*与肝硬化严重程度的相关性及评估肝动脉灌注和肝癌中心生物活性的潜力有待进一步研究。

要点

  • 口服葡萄糖后正常肝实质、肝癌肝实质及肝癌中心T2*值前后差异有统计学意义(p<0.01)。
  • 肝癌边缘T2*值口服葡萄糖前后无统计学差异(p=0.35)。
  • ΔT2*在健康志愿者与肝癌患者肝实质间及肝癌中心与边缘间差异有统计学意义(均p<0.01)。

核心结论

  • 葡萄糖作为BOLD fMRI刺激剂可能有助于评估肝硬化患者肝功能,ΔT2*与肝硬化严重程度的相关性及评估肝动脉灌注和肝癌中心生物活性的潜力有待进一步研究。

研究设计与样本

  • 可行性研究,纳入20例肝硬化肝细胞癌患者和10名健康志愿者,报告16例患者和10名健康志愿者数据;所有参与者口服葡萄糖前及口服后30分钟行BOLD fMRI,测量正常肝实质、肝癌肝实质、肝癌中心及肝癌边缘T2*值并计算ΔT2*。

诊断标准与关键数值

  • 口服葡萄糖前后正常肝实质、肝癌肝实质及肝癌中心T2*值差异有统计学意义(p<0.01)。
  • 口服葡萄糖前后肝癌边缘T2*值差异无统计学意义(p=0.35)。
  • 正常肝实质、肝癌肝实质、肝癌中心及肝癌边缘ΔT2*分别为2.8±1.1 ms、-1.3±1.2 ms、-2.1±1.8 ms、0.8±3.2 ms。
  • ΔT2*在健康志愿者与肝癌患者肝实质间及肝癌中心与肝癌边缘间差异有统计学意义(均p<0.01)。

局限性

  • 作者指出ΔT2*与肝硬化严重程度的相关性及评估肝动脉灌注和肝癌中心生物活性的潜力有待进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To explore the role of glucose as a stimulation agent in the blood oxygen level-dependent (BOLD) functional magnetic resonance imaging (fMRI) for liver cirrhosis and hepatocellular carcinoma (HCC).

MATERIALS AND METHODS: Twenty HCC patients with cirrhosis and 10 healthy volunteers were recruited. BOLD fMRI was performed for all participants prior to and 30 min after oral administration of glucose to measure the T2* values of normal liver parenchyma, HCC liver parenchyma, HCC center, and HCC edge. Variations of the T2*(△T2*) before and after administration were calculated.

RESULTS: Data from 16 patients and 10 healthy volunteers were reported. Before and after oral administration of glucose, T2* values of the normal liver parenchyma, HCC liver parenchyma, and HCC center were statistically different (p < 0.01), while no statistical difference was found in T2* value of the HCC edge (p = 0.35). △T2* values of the normal liver parenchyma, HCC liver parenchyma, HCC center, and HCC edge were 2.8 ± 1.1 ms, -1.3 ± 1.2 ms, -2.1 ± 1.8 ms, and 0.8 ± 3.2 ms before and after administration, respectively. △T2* value was statistically different in the liver parenchyma between healthy volunteers and HCC patients and between HCC center and HCC edge (both p < 0.01).

CONCLUSION: Use of glucose as the stimulation agent in BOLD fMRI may facilitate the assessment of liver function for patients with liver cirrhosis. The potential of △T2* to correlate with severity of liver cirrhosis, as well as to evaluate hepatic artery perfusion and bioactivity of HCC center should be further investigated.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Yuan F, Song B, Huang Z, et al. Glucose as a stimulation agent in the BOLD functional magnetic resonance imaging for liver cirrhosis and hepatocellular carcinoma: a feasibility study. Abdom Radiol (NY). 2018. PMID: 28730273. doi:10.1007/s00261-017-1264-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。